Jazz Pharmaceuticals (JAZZ) PT Raised to $235 at Barclays
Tweet
Share
E-mailGet Alerts JAZZ Hot Sheet
Price: $107.97 -0.32%
Rating Summary:
31 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 9
Rating Summary:
31 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 9
Join SI Premium – FREE
Barclays analyst Balaji Prasad raised the price target on Jazz Pharmaceuticals (NASDAQ: JAZZ) to $235.00 (from $233.00) while maintaining a Overweight rating.
You May Also Be Interested In
- TechnipFMC (FTI) PT Raised to $30 at BTIG
- JPMorgan Downgrades Beijing Easpring Material Technology Co Ltd. (300073:CH) to Underweight
- Radiant Opto-Electronics Corp (6176:TT) PT Raised to NT$162.50 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
